Differential role of β(1C) and β(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, Protein Kinase B/AKT, and Ras/mitogen- activated protein kinase pathways

Molecular Biology of the Cell

Volumn 11, Issue 7, 2000, Pages 2235-2249

  Fornaro, Mara ^a   Steger, Craig A ^a   Bennett, Anton M ^a   Wu, J Julie ^a   Languino, Lucia R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME PHOSPHORYLATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0033944543     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.11.7.2235     Document Type: Article

References (80)

1. 1 integrin subunit. J. Cell Biol. 727, 171-178.
2. 3 integrin associates with a 190-kDa protein that is phosphorylated on tyrosine in response to platelet-derived growth factor. J. Biol. Chem. 268, 17270-17276.
3. 1D integrin inhibits cell cycle progression in normal myoblasts and fibroblasts. J. Biol. Chem. 273, 15234-15240.
4. Belkin, A.M., Retta, S.F., Pletjushkina, O.Y., Balzac, F., Silengo, L., Fassler, R., Koteliansky, V.E., Burridge, K., and Tarone, G. (1997). Muscle β1D integrin reinforces the cytoskeleton-matrix link: modulation of integrin adhesive function by alternative splicing. J. Cell Biol. 139, 1583-1595.
5. Bennett, A.M., Hausdorff, S.F., O'Reilly, A.M., Freeman, R.M.J., and Neel, B.C. (1996). Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol. Cell. Biol. 16, 1189-1202.
6. Bennett, A.M., and Tonks, N.K. (1997). Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278, 1288-1291.
7. Bottazzi, M.E., and Assoian, R.K. (1997). The extracellular matrix and mitogenic growth factors control G1 phase cyclins and cyclin-dependent kinase inhibitors. Trends Cell Biol. 7, 348-352.
8. Brunet, A., Roux, D., Lenormand, P., Dowd, S., Keyse, S., and Pouyssegur, J. (1999). Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664-674.
9. Campbell, S.L., Khosravi-Far, R., Rossman, K.L., Clark, G.J., and Der, C.J. (1998). Increasing complexity of Ras signaling. Oncogene 17, 1395-1413.
10. Cary, L.A., and Guan, J.L. (1999). Focal adhesion kinase in integrin-mediated signaling. Front. Biosci. 4, 102-113.
11. Kip1 protein: prognostic implications in primary breast cancer. Nat. Med. 3, 227-230.
12. Chen, H.-C., Appeddu, P.A., Isoda, H., and Guan, J.-L. (1996a). Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 273, 26329-26334.
13. Chen, H.-C., Appeddu, P.A., Parsons, J.T., Hildebrand, J.D., Schaller, M.D., and Guan, J.-L. (1995). Interaction of focal adhesion kinase with cytoskeletal protein talin. J. Biol. Chem. 270, 16995-16999.
14. Chen, H.-C., and Guan, J.-L. (1994). Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 97, 10148-10152.
15. Chen, Q., Lin, T.H., Der, C.J., and Juliano, L.R. (1996b). Integrin-mediated activation of MEK and mitogen activated protein kinase is independent of Ras. J. Biol. Chem. 271, 18122-18127.
16. Clark, E., and Hynes, R. (1996). Ras activation is necessary for integrin-mediated activation of extracellular signal-regulated kinase 2 and cytosolic phospholipase A, but not for cytoskeletal organization. J. Biol. Chem. 271, 14814-14818.
17. Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., and Dedhar, S. (1998). Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. USA 95, 11211-11216.
18. Downward, J. (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10, 262-267.
19. Engvall, E., and Ruoslahti, E. (1977). Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer 20, 1-5.
20. Fornaro, M., and Languino, L.R. (1997). Alternatively spliced variants: a new view of the integrin cytoplasmic domain. Matrix Biol. 16, 185-193.
21. 1C inhibits prostate epithelial cell proliferation. Am. J. Pathol. 153, 1079-1087.
22. 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma. Am. J. Pathol. 149, 765-773.
23. 1C integrin in prostatic adenocarcinoma. J. Clin. Invest. 103, 321-329.
24. 1C cytoplasmic domain regulates cell proliferation. J. Biol. Chem. 270, 24666-24669.
25. Franke, T.F., Yang, S.I., Chan, T.O., Datta, K., Kazlauskas, A., Morrison, D.K., Kaplan, D.R., and Tsichlis, P.N. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the platelet-derived growth factor (PDGF)-activated phosphatidylinositol 3-kinase (PI 3-kinase). Cell 87, 727-738.
26. Frisch, S.M., and Ruoslahti, E. (1997). Integrins and anoikis. Curr. Opin. Cell Biol. 9, 701-706.
27. Frisch, S.M., Vuori, K., Ruoslahti, E., and Chanhui, P.Y. (1996). Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793-799.
28. Guadagno, T.M., and Ferrell, J.E. (1998). Requirement for MAPK activation for normal mitotic progression in Xenopus egg extracts. Science 282, 1312-1314.
29. Guan, J.L., Trevithick, J.E., and Hynes, R.O. (1991). Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul. 2, 951-964.
30. 1-integrin-linked protein kinase. Nature 379, 91-96.
31. Hemler, M.E. (1998). Integrin associated proteins. Curr. Opin. Cell Biol. 10, 578-585.
32. Hemler, M.E., Weitzman, J.B., Pasqualini, R., Kawaguchi, S., Kassner, P.D., and Berdichevsky, F.B. (1995). Structure, biochemical properties, and biological functions of integrin cytoplasmic domains. In: lntegrins: The Biological Problems, ed. Y. Takada, CRC Press, Boca Raton, FL. 1-35.
33. kip1. J. Clin. Invest. 103, 597-604.
34. Howe, A., Aplin, A.E., Alahari, S.K., and Juliano, R.L. (1998). Integrin signaling and cell growth control. Curr. Opin. Cell Biol. 10, 220-231.
35. FAK in cultured fibroblasts results in apoptosis. J. Cell Biol. 335, 1383-1390.
36. Hunter, T. (1997). Oncoprotein networks. Cell 88, 333-346.
37. Hynes, R.O. (1992). lntegrins: versatility, modulation and signaling in cell adhesion. Cell 69, 11-25.
38. Illic, D., Almeida, E.A.C., Schlaepfer, D.D., Dazin, P., Aizawa, S., and Damsky, C.H. (1998). Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143, 547-560.
39. Jiang, B.H., Aoki, M., Zheng, J.Z., Li, J., and Vogt, P.K. (1999). Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc. Natl. Acad. Sci. USA 96, 2077-2081.
40. kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15, 629-637.
41. Keely, P., Parise, L., and Juliano, R. (1998). Integrins and GTPases in tumor cell growth, motility and invasion. Trends Cell Biol. 8, 101-106.
42. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P.H., and Downward, J. (1997). Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783-2793.
43. King, W.G., Mattaliano, M.D., Chan, T.O., Tsichlis, P.N., and Brugge, J.S. (1997). Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 27, 4406-4418.
44. 1 integrins. Proc. Natl. Acad. Sci. USA 88, 8392-8396.
45. Languino, L.R., Plescia, J., Duperray, A., Brian, A.A., Plow, E.F., Geltosky, J.E., and Altieri, D.C. (1993). Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1 dependent pathway. Cell 73, 1423-1434.
46. 1 subunit with a variant cytoplasmic domain. J. Biol. Chem. 267, 7116-7120.
47. 1 cytoplasmic domain mutants. Mol. Biol. Cell 6, 151-160.
48. Lin, T.H., Aplin, A.E., Shen, Y., Chen, Q., Schaller, M., Romer, L., Aukhil, I., and Juliano, R.L. (1997). Integrin-mediated activation of MAP kinase is independent of FAK evidence for dual integrin signaling pathways in fibroblasts. J. Cell Biol. 136, 1385-1395.
49. Loda, M., Cukor, B., Tam, S.W., Lavin, P., Fiorentino, M., Draetta, G.F., Jessup, J.M., and Pagano, M. (1997). Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3, 231-234.
50. 4 integrin to Ras-MAP kinase pathways mediated by She controls keratinocyte proliferation. EMBO J. 16, 2365-2375.
51. 1C integrin in breast carcinomas correlates with high proliferative fraction, high histological grade, and larger size. Am. J. Pathol. 356, 169-174.
52. 1C. Science 269, 1570-1572.
53. 1C. J. Biol. Chem. 274, 8111-8116.
54. Miranti, C.K., Ohno, S., and Brugge, J.S. (1999). Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of She. J. Biol. Chem. 274, 10571-10581.
55. Pfaff, M., Liu, S., Erle, D.J., and Ginsberg, M.H. (1998). Integrin β cytoplasmic domains differentially bind to cytoskeletal proteins. J. Biol. Chem. 273, 6104-6109.
56. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 3, 222-226.
57. Rameh, L.E., and Cantley, L.C. (1999). The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274, 8347-8350.
58. Rebollo, A., and Martinez-A, C. (1999). Ras proteins: recent advances and new functions. Blood 94, 2971-2980.
59. Retta, S.F., Balzac, F., Ferraris, P., Belkin, A.M., Fassler, R., Humphries, M.J., De Leo, G., Silengo, L., and Tarone, G. (1998). β1-Integrin cytoplasmic subdomains involved in dominant negative function. Mol. Biol. Cell 9, 715-731.
60. Robinson, M.J., and Cobb, M.H. (1997). Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9, 180-186.
61. Sastry, S.K., Lakonishok, M., Wu, S., Truong, T.Q., Huttenlocher, A., Turner, C.E., and Horwitz, A.F. (1999). Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal. J. Cell Biol. 144, 1295-1309.
62. Schlaepfer, D.D., Hanks, S.K., Hunter, T., and van der Geer, P. (1994). Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372, 786-791.
63. Schlaepfer, D.D., and Hunter, T. (1997). Focal adhesion kinase over-expression enhances ras-dependent integrin signaling to ERK2/ mitogen-activated protein kinase through interactions with and activation of c-Src. J. Biol. Chem. 272, 13189-13195.
64. Schlaepfer, D.D., and Hunter, T. (1998). Integrin signaling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol. 8, 151-157.
65. Schlaepfer, D.D., Jones, K.C., and Hunter, T. (1998). Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and Focal Adhesion Kinase-initiated tyrosine phosphorylation events. Mol. Cell. Biol. 28, 2571-2585.
66. Schwartz, M.A., Schaller, M.D., and Ginsberg, M.H. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 71, 549-599.
67. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
68. Sieg, D.J., Hauck, C.R., and Schlaepfer, D.D. (1999). Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 112, 2677-2691.
69. 1 to fibronectin and invasion but not recruitment to adhesion plaques. J. Cell Biol. 119, 913-921.
70. Taylor, S.J., and Shalloway, D. (1996). Cell cycle-dependent activation of Ras. Curr. Biol. 6, 1621-1627.
71. Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res. 58, 542-548.
72. Wary, K.K., Mainiero, F., Isakoff, S.J., Marcantonio, E.E., and Giancotti, F.G. (1996). The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell 87, 733-743.
73. Wary, K.K., Mariotti, A., Zurzolo, C., and Giancotti, F.G. (1998). A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94, 625-634.
74. Wei, J., Shaw, L.M., and Mercurio, A.M. (1998). Regulation of mitogen-activated protein kinase activation by the cytoplasmic domain of the α6 integrin subunit. J. Biol. Chem. 273, 5903-5907.
75. Xu, L.-H., Owens, L.V., Sturge, G.C., Yang, X., Liu, E.T., Craven, R.J., and Cance, W.G. (1996). Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ. 7, 413-418.
76. Yamakita, Y., Totsukawa, G., Yamashiro, S., Fry, D., Zhang, X., Hanks, S.K., and Matsumura, F. (1999). Dissociation of FAK/ p130CAS/c-src complex during mitosis: role of mitosis-specific serine phosphorylation of FAK. J. Cell Biol. 144, 315-324.
77. Yang, R.M., Naitoh, J., Murphy, M., Wang, H.J., Phillipson, J., deKernion, J.B., Loda, M., and Reiter, R.E. (1998). Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol. 159, 941-945.
78. Yatohgo, T., Izumi, M., Kashiwagi, H., and Hayashi, M. (1988). Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13, 281-292.
79. Zhao, J.H., Reiske, H., and Guan, J.L. (1998). Regulation of the cell cycle by focal adhesion kinase. J. Cell Biol. 143, 1997-2008.
80. Zheng, D.Q., Woodard, A.S., Fornaro, M., Tallini, G., and Languino, L.R. (1999). Prostatic carcinoma cell migration via αVβ3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res. 59, 1655-1664.